Vascular Stents Market Set to Surge from 2024 to 2035 Driven by Cardiovascular Care Innovations
Experts predict strong and sustained growth for the global vascular stents market in the next ten years. In 2024, the market will be valued at USD 11.3 billion and is expected to grow to USD 23.5 billion by 2035 at a CAGR of around 6.9% in the period from 2025 to 2035. The main factors contributing to this growth include more cases of heart problems, a larger aging population, and the routine use of less-invasive surgery. The use of vascular stents, small mesh tubes put into blood vessels to help with blood flow, is now standard in coronary artery disease and other vascular conditions. Advances in technology, mainly with drug-eluting and bioresorbable stents, are improving medical care for vascular diseases and encouraging more opportunities for the market. Coronary artery stents, peripheral stents, and others form the major products in the market. On the other hand, stents may be milled from metal, polymer, or hybrid materials, and they are essentially delivered across the body using balloon-expanding or self-expanding methods. Growing interest in bioabsorbable vascular scaffolds, a rise in the number of stents being used for interventions, and greater healthcare spending in developing countries represent main opportunities.
Request Sample-https://www.metatechinsights.c....om/request-sample/11
Important Market Drivers
There are two major reasons that the market is growing so quickly. According to the World Health Organization (WHO), nearly 18 million people die each year due to cardiovascular diseases, and coronary artery disease faces the biggest number. Because of this critical health issue, vascular stents are being used more and more in the treatment process. Another reason is that having minimally invasive procedures helps people spend less time in the hospital and recovers quicker.
Coronary Artery Stents
The coronary artery stents segment is the biggest part of the global market because cardiac heart disease is very common and more heart procedures are being done to fix it. Key drivers include more people dealing with things like high blood pressure, diabetes, and being overweight. Continuous innovation in drug-eluting stents (DES) and bringing in newer stent designs that lower the risk of blockages and blood clots are helping stents stay the most popular choice for heart procedures, both inside and outside of hospitals.
Full Report-https://www.metatechinsights.c....om/industry-insights
Balloon Expandable Stents
Among delivery methods, balloon expandable stents are growing a lot lately, especially when they're used during coronary procedures. Their ability to stretch just the right amount, stay in place, and work well with pressurized balloons make them very helpful for treating tougher problems and important blood vessels. Improved material strength and being able to deliver the devices well have let cardiologists do their jobs safer and faster, so more hospitals and heart clinics are now using them.
North America Vascular Stents Market
North America continues to have the biggest portion of worldwide vascular care because they have good healthcare systems, a lot of procedures done each year, and often try out new vascular treatments first. The U.S. has a lot of people who are getting older and who often get heart problems from things like bad diet and too little exercise. Government and private insurance companies’ rules for paying for medical devices, high levels of research and development, and more clinical trials are helping the market grow and become bigger.
Buy Now-https://www.metatechinsights.com/checkout/1141
Competitive Landscape and Industry Players
The global vascular stents market is pretty competitive, as companies put efforts into creating new treatments, merging together, buying each other out, and working together with others. Major companies in the stent industry are Boston Scientific, Abbott, Medtronic, Terumo, Biotronik, Cook Medical, B. Braun, Cordis, MicroPort, and Endologix. These companies are working on making new types of vascular stents, using drugs to help release medications more slowly, and trying to reach more customers in fast-growing areas by teaming up with other companies and bringing out new products.
